Skip to main content
رجوع
BWAY logo

BrainsWay Ltd.

جودة البيانات: 100%
BWAY
NASDAQ Healthcare Medical - Devices
KWD 13.50
▼ KWD 0.21 (-1.53%)
القيمة السوقية: 529.51M
نطاق اليوم
KWD 13.19 KWD 13.70
نطاق 52 أسبوعًا
KWD 3.92 KWD 14.65
حجم التداول
119,498
متوسط 50 يوم / 200 يوم
KWD 12.15 / KWD 8.61
الإغلاق السابق
KWD 13.71

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 68.8 0.3
P/B 7.2 2.9
ROE % 11.4 3.7
Net Margin % 14.6 3.8
Rev Growth 5Y % 15.4 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 30.000 +122.2%
مكرر الربحية المستقبلي
70.3
ربحية السهم المستقبلية
KWD 0.195
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
66 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2028 KWD 0.280
KWD 0.271 – KWD 0.289
110 M 1
FY2027 KWD 0.277
KWD 0.197 – KWD 0.387
81 M 3
FY2026 KWD 0.195
KWD 0.157 – KWD 0.264
66 M 3

النقاط الرئيسية

Revenue grew 15.42% annually over 5 years — strong growth
Earnings grew 163.39% over the past year
ROE of 11.35% — decent returns on equity
Debt/Equity of 0.09 — conservative balance sheet
Generating 16.40M in free cash flow
P/E of 68.83 — premium valuation

النمو

Revenue Growth (5Y)
15.42%
Revenue (1Y)28.34%
Earnings (1Y)163.39%
FCF Growth (3Y)N/A

الجودة

Return on Equity
11.35%
ROIC4.08%
Net Margin14.62%
Op. Margin8.28%

الأمان

Debt / Equity
0.09
Current Ratio3.83
Interest Coverage1.96

التقييم

P/E Ratio
68.83
P/B Ratio7.23
EV/EBITDA107.49
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 28.34% Revenue Growth (3Y) 28.69%
Earnings Growth (1Y) 163.39% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15.42% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 52.64M Net Income (TTM) 7.69M
ROE 11.35% ROA 6.81%
Gross Margin 75.42% Operating Margin 8.28%
Net Margin 14.62% Free Cash Flow (TTM) 16.40M
ROIC 4.08% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.09 Current Ratio 3.83
Interest Coverage 1.96 Dividend Yield 0.00%
Valuation
P/E Ratio 68.83 P/B Ratio 7.23
P/S Ratio 10.06 PEG Ratio 0.06
EV/EBITDA 107.49 Dividend Yield 0.00%
Market Cap 529.51M Enterprise Value 468.38M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 52.64M 41.02M 31.79M 27.18M 29.66M
Net Income 7.69M 2.92M -4.20M -13.35M -6.46M
EPS (Diluted) 0.36 0.09 -0.13 -0.43 -0.21
Gross Profit 39.70M 30.58M 23.48M 20.05M 23.06M
Operating Income 4.36M 1.39M -4.96M -12.68M -5.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 112.92M 94.32M 62.97M 64.48M 75.73M
Total Liabilities 34.67M 32.00M 21.39M 19.08M 18.41M
Shareholders' Equity 73.22M 62.31M 41.58M 45.40M 57.33M
Total Debt 6.82M 5.62M 471,000.0 488,000.0 754,000.0
Cash & Equivalents 67.95M 69.35M 10.52M 47.58M 16.92M
Current Assets 84.89M 79.67M 55.47M 58.09M 65.45M
Current Liabilities 22.16M 15.35M 9.76M 8.14M 9.07M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#787 of 1052
32
Custom Full Throttle
#144 of 146
7

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026
دخل Full Throttle
Mar 24, 2026